Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: John Thompson, Christopher Cunniff

Premium

Transgenomics has appointed John Thompson as a Class II director of the firm. He will also serve on the audit committee of the company's board of directors. Thompson was previously senior vice president of strategy and corporate development at Invitrogen and was also previously senior vice president of strategy and business development at Dexter.


New York-Presbyterian/Weill Cornell Medical Center has appointed Christopher Cunniff to the director of the division of medical genetics. Previously, Cunniff was chief of medical and molecular genetics at the University of Arizona College of Medicine. He also served as co-medical director of the Children's Clinics for Rehabilitative Services and was recently a professor of pediatrics with joint appointments in pathology, public health, and obstetrics and gynecology at the University of Arizona College of Medicine. He also previously served as secretary of the American College of Medical Genetics and as president of the American Board of Medical Genetics.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.